COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Oct 8

<< Previous

Bullboard Posts

Next >>

Post by Hopeforthebeston Jul 25, 2024 8:45am

132 Views

Post# 36147607

Re: Oct 8

Hey proph that they will finally announce to commissioning of the PGX 50 scale is finally completed, after all it has been almost 8 months after the promised completion date and in true gagnon fashion failure and delays and lies

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3